General MedicationsINTRAMUSCULAR, INTRAVENOUSGeneric

CEFUROXIME SODIUM

Standard Dose

EQ 1.5GM BASE/VIAL

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview CEFUROXIME SODIUM is listed in Drugs@FDA under application 064192 (ANDA).

Marketing status: Discontinued Active ingredient CEFUROXIME SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 1.5GM BASE/VIAL Sponsor TEVA PHARMS Submission history Latest submission status date: 2002-12-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFUROXIME SODIUM is listed in Drugs@FDA under application 064192 (ANDA). Marketing status: Discontinued Active ingredient CEFUROXIME SODIUM Form and strength INJECTABLE;INTRAMUSCULAR, INTRAVENOUS - EQ 1.5GM BASE/VIAL Sponsor TEVA PHARMS Submission history Latest submission status date: 2002-12-12 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.